Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 34, Issue 11, pp 1445–1448 | Cite as

Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review

  • Michelle MatthewsEmail author
  • Rebecca Pollack
Fertility Preservation

Abstract

Purpose

Hematopoietic stem cell transplantation (HSCT) is a cure for sickle cell disease (SCD) but frequently results in permanent sterility. The complications associated with oocyte cryopreservation and risks of future pregnancy are increased in SCD patients. This case report discusses risk reduction strategies and includes a literature review of pregnancy after HSCT.

Case

A 23-year-old woman underwent ovarian stimulation for fertility preservation resulting in cancelation due to acute pain crisis. She underwent a successful oocyte retrieval after exchange transfusion to decrease her hemoglobin S to 30%. This is the second report of a pain crisis in a woman with SCD undergoing oocyte banking.

Conclusion(s)

Women with SCD undergoing fertility preservation may be at increased risk of complications from ovarian stimulation. Risks in pregnancy after HSCT should also be considered before proceeding with fertility preservation.

Keywords

Sickle cell disease Fertility preservation Pain crisis Stem cell transplantation 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Kato GJ, McGowan V, Machado RF, Little JA, Taylor J 6th, Morris CR, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279–85.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Pleasants S. Epidemiology: a moving target. Nature. 2014;515(7526):S2–3.CrossRefPubMedGoogle Scholar
  3. 3.
    Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, et al. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA. 2014;312(1):48–56.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bhatia M, Walters MC. Hematopoietic stem cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant. 2008;41:109–17.CrossRefPubMedGoogle Scholar
  5. 5.
    Aboud MR. Hematopoietic stem-cell transplantation for adults with sickle cell disease. NEJM. 2009;361(24):2380–1.CrossRefGoogle Scholar
  6. 6.
    Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol. 1988;6(5):813–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Schimmer AD, Quatermain M, Imrie K, Ali V, McCrae J, Stewart AK, et al. Ovarian function after autologous bone marrow transplantation. J Clinical Oncol. 1998;16(7):2359–63.CrossRefGoogle Scholar
  8. 8.
    Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.Google Scholar
  9. 9.
    Society for Assisted Reproductive Technology (SART) national summary report. https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0. Accessed 12/29/16.
  10. 10.
    Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100:1214–23.Google Scholar
  11. 11.
    Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–52.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Shanis D, Merideth M, Pulanic T, Savani B, Battiwalla M, Stratton P. Female long term survivors after allo-HSCT: evaluation and management. Semin Hematol. 2012;49(1):83–93.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87(7):3045–52.PubMedGoogle Scholar
  14. 14.
    Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Liungman P, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001;358(9278):271–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Yoong WC, Tuck SM. Menstrual pattern in women with sickle cell anaemia and its association with sickling crises. J Obstet Gynaecol. 2002;22(4):399–401.CrossRefPubMedGoogle Scholar
  16. 16.
    Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–48.CrossRefPubMedGoogle Scholar
  17. 17.
    Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomized, controlled, multicentre clinical trial. Lancet. 2013;381(9870):930–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Naik RP, Streiff MB, Lanzkron S. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013 April;35(3):352–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Howard J, Oteng-Ntim E. The obstetric management of sickle cell disease. Best Pract Res Clin Obstet Gynaecol. 2012;26:25–36.CrossRefPubMedGoogle Scholar
  20. 20.
    Al Jama FE, Gasem T, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital. Eastern Saudi Arabia Arch Gynecol Obstet. 2012;280(5):793–7.CrossRefGoogle Scholar
  21. 21.
    Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS, et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant. 2006;37(11):1023–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2011;17(2):157–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Hammer RA, Urnes PD, Lurain JR. Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report. J Reprod Med. 1996;41(5):372–4.PubMedGoogle Scholar
  24. 24.
    Norwitz ER, Stern HM, Grier H, Lee-Parritz A. Placenta percreta and uterine rupture associated with prior whole body radiation therapy. Obstet Gynecol. 2001;98(5 Pt 2):929–31.PubMedGoogle Scholar
  25. 25.
    Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion. Fertil Steril. 2016; 106(6):1319–23.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Division of Reproductive Endocrinology, Levine Cancer InstituteCarolinas Healthcare SystemCharlotteUSA
  2. 2.The Women’s InstituteCharlotteUSA
  3. 3.Division of Maternal-Fetal MedicineCarolinas HealthCare SystemCharlotteUSA

Personalised recommendations